Trading in Novo Nordisk shares by board members, executives and associated persons on 7 May 2021
May 07, 2021 15:54 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 7 May 2021 — This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance...
Novo Nordisk A/S – Share repurchase programme
May 07, 2021 15:31 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 7 May 2021 — As part of the up to DKK 18 billion 2021 share repurchase programme, Novo Nordisk A/S has now initiated a new share repurchase programme for an amount of up to DKK 3.3...
Novo Nordisk A/S purchases B shares worth DKK 2,586 million from Novo Holdings A/S under the 2021 share repurchase programme
May 07, 2021 15:24 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 7 May 2021 — Novo Nordisk A/S has today entered into an agreement to purchase 5,610,000 B shares of DKK 0.20 to a value of DKK 2,586 million from Novo Holdings A/S. This transaction...
Novo Nordisk's net profit increased by 6% in the first three months of 2021
May 05, 2021 01:30 ET
|
Novo Nordisk A/S
Financial report for the period 1 January 2021 to 31 March 2021Operating profit decreased by 8% in Danish kroner and increased by 3% at constant exchange rates (CER). Sales remained...
Novo Nordisk A/S – Share repurchase programme
May 04, 2021 10:38 ET
|
Novo Nordisk A/S
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 4 May 2021 – On 3 February 2021, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No...
Novo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 29 April 2021
April 29, 2021 05:00 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 29 April 2021 – In accordance with Section 32 of the Danish Capital Markets Act, Novo Nordisk A/S is required to publish the total number of voting rights and the size of the share...
Novo Nordisk A/S - Articles of Association
April 27, 2021 09:22 ET
|
Novo Nordisk A/S
Novo Nordisk's Articles of Association 2021
Attachment
210427_NN_Articles_of_Association_2021
...
Novo Nordisk A/S – Reduction of the share capital
April 27, 2021 09:14 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 27 April 2021 – At Novo Nordisk’s Annual General Meeting on 25 March 2021, it was decided to reduce the company’s B share capital from DKK 362,512,800 to DKK 354,512,800 by...
Novo Nordisk A/S – Share repurchase programme
April 26, 2021 05:05 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 26 April 2021 – On 3 February 2021, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Novo Nordisk to initiate phase 3a development in obesity with oral semaglutide
April 21, 2021 09:52 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 21 April 2021 – Novo Nordisk today announced the decision to enter phase 3a development in obesity with oral semaglutide 50 mg. The decision follows the completion of the STEP phase...